A Randomized, Open-label, Single-dose, Cross-over Phase 1 Study to Evaluate the Effect of Food on Pharmacokinetic Characteristics and Safety of CKD-379 in Healthy Adult Volunteers
Latest Information Update: 03 Jan 2025
Price :
$35 *
At a glance
- Drugs Empagliflozin/Metformin/Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Chong Kun Dang
- 30 Dec 2024 Status changed from not yet recruiting to completed.
- 28 Oct 2024 New trial record